A new contraceptive for men which is supposed to be a reversible vasectomy has been successfully tested on monkeys and could soon be set for human trials.
‘Vasalgel’ is the drug, and developers are hoping to get the green light from regulators for human trials to commence so they can look at bringing it to market.